Protecting U.S. Intellectual Property & Innovation Leadership: December 16, 2021
American innovation leadership rests on a foundation of rewarding breakthroughs through patents and intellectual property protections. The protections provide the incentives that encourage innovators to invest in R&D and create new technologies while also allowing U.S. innovators and companies to lead in setting global technology standards. Now, facing threats to our national security and economic prosperity, it is more important than ever to ensure U.S. technology leadership, protect our vital intellectual property, and set the standards for future critical technologies.
Join the discussion on Thursday, 16 December, 2.00 – 3.00 PM ET and register here.
Patenting and Covid-19 Vaccines
Patents have had an important role in organising the collaborations that led to the development and commercialization of COVID-19 vaccines. Patenting is a crucial tool in research-based industries like pharmaceuticals and biologics and can be a means to encourage collaboration. Terms can be negotiated to have different types of expertise combined in one project. The virus will likely garner another sort of PIP-type or any other similar program which will encourage contractual licensing of innovative IP in exchange for access to specialized expertise or important biological data. Monopolisation should clearly be avoided, and patent pooling must be the way forward to obtain sufficient vaccines for Covid-19 as early as possible.